This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
S

ASCO® 2024 Insights: "PALOMA-2 Study - Subcutaneous Amivantamab & Lazertinib as 1L Treatment in Patients With EGFRm Advanced NSCLC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Sun Min Lim
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Sun Min Lim
124 views
June 11, 2024

Chapters

PALOMA-2 Study & Drug Overview

00:00

Efficacy & Safety in EGFRm NSCLC

01:22

Treatment Results & PK Consistency

06:11

Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

2024 ASCO® Annual Meeting Insights Hub: Lung Videos

17:22

ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths, IO …

2024 ASCO® Annual Meeting Insights Hub

A. Chiang

406 views

·

4 months ago
40:00

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

ecancer

B. Gyawali

97 views

·

4 months ago
04:26

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consol…

ecancer

P. Iyengar

37 views

·

4 months ago
View All

Recommended

08:49

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

2.5K views

·

7 months ago
27:06

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

837 views

·

1 month ago
35:40

Year in Review: Lung Cancer

Balazs Halmos

2.6K views

·

10 months ago
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

·

7 months ago
08:49

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

733 views

·

1 month ago
57:44

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.1K views

·

1 year ago
27:04

Cancer Screening Molecular Tools

Fengting Yan

2.5K views

·

11 months ago
36:14

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

810 views

·

4 months ago
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

·

7 months ago
02:41

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

593 views

·

6 months ago
16:10

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…

2024 ASCO® Annual Meeting Insights Hub

L. Raez

679 views

·

5 months ago
11:07

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implicat…

Insights from 2023 ASCO® Annual Meeting

J. West

2.3K views

·

1 year ago
26:38

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

318 views

·

1 month ago
07:43

2024 Updates on NSCLC Targeted Therapies: FLAURA2 Trial - Osimertini…

Yale Cancer Center

P. Janne

696 views

·

8 months ago
16:57

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

678 views

·

5 months ago
26:21

NSCLC & Targeted Therapy: A Brief Overview and Update in the Metasta…

Memorial Sloan Kettering Cancer Center

M. Hwang

977 views

·

11 months ago
17:34

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

909 views

·

8 months ago
16:12

2024 Updates on the Fast-Changing NSCLC Landscape

Total Health

R. Osarogiagbon

447 views

·

8 months ago
07:32

WCLC 2024 Insights: MARIPOSA - Amivantamab + Lazertinib vs. Osimerti…

Insights from 2024 WCLC

S. Gadgeel

249 views

·

2 months ago
19:33

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

499 views

·

4 months ago
AUTOPLAY